-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Downgrades Amphastar Pharma to Hold, Lowers Price Target to $22

Benzinga·04/21/2026 16:02:00
Listen to the news
Jefferies analyst Dennis Ding downgrades Amphastar Pharma (NASDAQ:AMPH) from Buy to Hold and lowers the price target from $30 to $22.